开发与测试用于评估中国慢阻肺患者的附加条目版EQ-5D-5L:混合方法研究方案
本研究方案旨在为EQ-5D-5L开发呼吸相关附加条目(bolt-on),以提高其在中国慢阻肺患者健康相关生活质量评估中的敏感性。研究采用混合方法:先通过内容回顾、专家咨询和患者定性访谈识别并开发候选条目,再在慢阻肺患者中定量评估其心理测量学特性,包括重测信度、结构效度、已知组效度和维度结构等。
要点
- EQ-5D在慢阻肺患者中检测健康变化敏感性不足,附加条目可能改善。
- 研究分定性(条目开发)与定量(心理测量学测试)两阶段。
- 定量阶段将评估重测信度、效度、维度结构及解释力。
核心结论
- 基于EQ-5D开发呼吸相关附加条目,为慢阻肺患者HRQoL测量提供新方法,并可为其他疾病附加条目开发提供参考。
研究设计与样本
- 混合方法研究方案:先内容回顾慢阻肺特异性工具,再专家咨询和患者定性访谈开发候选附加条目,最后在慢阻肺患者中定量测试心理测量学特性。
关键数值与推荐
- 重测信度:总分用组内相关系数,条目层面用加权kappa统计量。
- 结构效度:用Spearman秩相关评估聚合与区分效度。
- 已知组效度:用方差分析比较EQ-5D-5L与EQ-5D-5L加附加条目得分在临床定义亚组间的差异。
- 维度结构:用最大似然提取和Promax旋转的探索性因子分析。
- 解释力:以EQ视觉模拟量表为因变量的普通最小二乘回归,并用Shorrocks–Shapley分解量化各条目贡献。
临床怎么用
- 若附加条目心理测量学特性良好,可提升EQ-5D-5L在中国慢阻肺患者中检测健康状态变化的敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction The EuroQol five dimensions questionnaire (EQ-5D) is widely used as a health-related quality of life (HRQoL) measure worldwide, but its sensitivity in detecting changes in health status among individuals with chronic obstructive pulmonary disease (COPD) remains suboptimal. Adding additional HRQoL dimensions (bolt-on items) to EQ-5D may enhance its sensitivity to specific diseases while preserving the original EQ-5D descriptive system. This study protocol documents the identification, development, selection and psychometric testing of respiratory-related bolt-on items for assessing COPD in China. Methods and analysis We will conduct a content review of the COPD disease-specific instruments to identify potential deficiencies in dimensions covered by the EQ-5D. Drawing from the dimensions identified in the content review, we will consult with clinical experts and conduct qualitative interviews with patients to identify and develop candidate bolt-on items that are relevant to COPD. Then, in the quantitative phase, we will assess the psychometric properties of the candidate bolt-on items among patients with COPD in China. Test–retest reliability will be examined using intraclass correlation coefficients for total scores and weighted kappa statistics for item-level agreement. Construct validity will be evaluated through convergent and divergent validity analyses using Spearman’s rank correlations. Known-groups validity will be tested by comparing five-level EQ-5D version (EQ-5D-5L) and EQ-5D-5L plus bolt-on scores across clinically defined subgroups using analysis of variance. The dimensional structure will be explored using exploratory factor analysis with maximum likelihood extraction and Promax rotation. Explanatory power will be assessed through ordinary least-squares regression with EQ visual analogue scale as the dependent variable, supported by Shorrocks–Shapley decomposition to quantify the contribution of each item to the explained variance. Discussion Based on the EQ-5D, Our study offers a new approach to measuring HRQoL in patients with COPD. Furthermore, it may offer valuable insights and serve as a reference for the development of bolt-on items for other diseases. Ethics and dissemination This study has received ethical approval from the Ethics Committee of the Centre for Health Management and Policy Research at Shandong University (no. ECSHCMSDU20240301).
引用
- BMJ Open Respiratory Research:Developing and testing bolt-on enhanced EQ-5D-5L for assessing Chinese patients with chronic obstructive pulmonary disease: a mixed-methods study protocol
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。